Researchers discover novel way to make breast cancer cells die

by Steve Lundeberg,Oregon State UniversityCredit:ACS Pharmacology & Translational Science(2024). DOI: 10.1021/acsptsci.3c00360Oregon State University researchers have discovered

Updated on: July 08,2024

Researchers discover novel way to make breast cancer cells die

by Steve Lundeberg,Oregon State UniversityCredit:ACS Pharmacology & Translational Science(2024). DOI: 10.1021/acsptsci.3c00360Oregon State University researchers have discovered

Updated on:July 08,2024

New treatment option for prostate cancer shows successful outcomes

by The Reis GroupCredit: CC0 Public DomainA minimally-invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to n

Updated on: March 30,2024

New treatment option for prostate cancer shows successful outcomes

by The Reis GroupCredit: CC0 Public DomainA minimally-invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to n

Updated on:March 30,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024

Common hair loss and prostate drug may also cut heart disease risk

by Lauren Quinn,University of Illinois at Urbana-ChampaignFinasteride decreases plaque size and macrophage content in Ldlr-/-mice. Four-week-old male Ldlr-/-mice were fed Western die

Updated on: March 25,2024

Common hair loss and prostate drug may also cut heart disease risk

by Lauren Quinn,University of Illinois at Urbana-ChampaignFinasteride decreases plaque size and macrophage content in Ldlr-/-mice. Four-week-old male Ldlr-/-mice were fed Western die

Updated on:March 25,2024

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on: November 15,2024

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on:November 15,2024

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but

Updated on: March 29,2024

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but

Updated on:March 29,2024

Benefit of risk-based breast cancer screening is still unclear

by Austrian Institute for Health Technology Assessment GmbHCredit: Unsplash/CC0 Public DomainThe Austrian Institute for Health Technology Assessment (AIHTA) has analyzed whether risk-based breast canc

Updated on: December 25,2023

Benefit of risk-based breast cancer screening is still unclear

by Austrian Institute for Health Technology Assessment GmbHCredit: Unsplash/CC0 Public DomainThe Austrian Institute for Health Technology Assessment (AIHTA) has analyzed whether risk-based breast canc

Updated on:December 25,2023

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published

Updated on: March 21,2024

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published

Updated on:March 21,2024

Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

by National Research University Higher School of EconomicsCredit: CC0 Public DomainScientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Science

Updated on: June 24,2024

Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

by National Research University Higher School of EconomicsCredit: CC0 Public DomainScientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Science

Updated on:June 24,2024

Researchers discover critical process for how breast cancer spreads in bones

by Brandi Wampler,University of Notre DameScientist Laurie Littlepage works with graduate student Ricardo Romero Moreno in her lab at the Harper Cancer Research Institute. Credit: Barbara Johnst

Updated on: June 19,2024

Researchers discover critical process for how breast cancer spreads in bones

by Brandi Wampler,University of Notre DameScientist Laurie Littlepage works with graduate student Ricardo Romero Moreno in her lab at the Harper Cancer Research Institute. Credit: Barbara Johnst

Updated on:June 19,2024

Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

by Candace Gwaltney,Indiana UniversityIdentification of pancreatic cancer architecture. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01914-4Indiana University Melvin and Bre

Updated on: November 11,2024

Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

by Candace Gwaltney,Indiana UniversityIdentification of pancreatic cancer architecture. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01914-4Indiana University Melvin and Bre

Updated on:November 11,2024

The role of p53 as a target for novel cancer therapies

by Erika Rindsjö,Karolinska InstitutetComplex interplay between TP53-mutant cancer cells and their microenvironment. Credit:Nature Reviews Clinical Oncology(2023). DOI: 10.1038/s4157

Updated on: December 30,2023

The role of p53 as a target for novel cancer therapies

by Erika Rindsjö,Karolinska InstitutetComplex interplay between TP53-mutant cancer cells and their microenvironment. Credit:Nature Reviews Clinical Oncology(2023). DOI: 10.1038/s4157

Updated on:December 30,2023